Home / Products / Genome-edited Cells / Bahcc1 Knockout RAW 264.7 Cell Line

Bahcc1 Knockout RAW 264.7 Cell Line

Cat. No. ARG43745
Product Type:

In Stock Cell Lines

Species:

Mus musculus (Mouse)

Tissue Source:

Ascites

Growth Properties:

Adherent

In stock
Request a Quote

Short Description

Bahcc1 Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited murine macrophage line disrupted for Bahcc1, which encodes the chromatin-associated protein BAHCC1. BAHCC1 is regulated by TLR ligands and cytokines, interacts with Histone H3 and chromatin remodelers, and governs immune gene transcription. This model enables study of BAHCC1-dependent epigenetic control in macrophage activation and polarization. The RAW 264.7 macrophage background supports investigations into innate immune signaling and chromatin biology. Applications include ChIP-qPCR, RNA-seq, flow cytometry, and reporter assays to dissect BAHCC1??s roles in inflammatory disorders and hematological malignancy research.

Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Species:
Mus musculus (Mouse)
Tissue Source:
Ascites
Disease:
Leukemia
Growth Properties:
Adherent
Donor Age:
Adult
Donor Sex:
Male

Cell Engineering Information

Gene Name:
BAHCC1
Gene Identifier:
NCBI Gene ID 268515

Immortalization Information

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Sterility testing:
The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description

Bahcc1 Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from Mus musculus RAW 264.7 macrophages. This gene-edited model features targeted disruption of the Bahcc1 gene, which encodes BAH and coiled-coil domain-containing protein 1, a putative chromatin-associated factor. The knockout cell line provides a loss-of-function system for investigating Bahcc1??s role in transcriptional regulation and epigenetic processes within an immune cell context.

RAW 264.7 is an Abelson murine leukemia virus-induced tumor-derived macrophage cell line widely used for studying monocytic/macrophage immune responses. These cells exhibit robust responsiveness to various immune stimuli and are a well-established model for macrophage activation, polarization, and signal transduction. The BALB/c-derived line retains many functional characteristics of primary macrophages, including phagocytic activity and inducible cytokine production, making it a suitable platform for genetic manipulation to dissect regulatory mechanisms in innate immunity.

BAHCC1 is predicted to function as a chromatin-associated protein that recognizes specific histone modifications, such as methylated Histone H3, through its BAH domain. Via its coiled-coil domain, it oligomerizes and integrates into chromatin remodeling complexes, thereby modulating access of transcriptional machinery to gene regulatory regions. In macrophages, BAHCC1 activity is regulated by upstream signals including Toll-like receptor (TLR) ligands, inflammatory cytokines, and cellular stress signals. Downstream, BAHCC1 influences the transcription of cytokine genes and broader immune response programs. It interacts with core histones, chromatin remodelers, and transcription factors, positioning it within pathways that convert extrinsic stimuli into epigenetic changes controlling gene expression.

In RAW 264.7 cells, BAHCC1 is implicated in coordinating macrophage activation and polarization decisions by linking signal-responsive chromatin dynamics to transcriptional outputs. The knockout model thus allows dissection of how BAHCC1-dependent epigenetic regulation shapes macrophage phenotype during responses to pro-inflammatory or anti-inflammatory cues. Its disruption may alter the expression kinetics of key cytokines and activation markers, providing insight into macrophage plasticity and the epigenetic gating of immune gene loci.

The Bahcc1 Knockout RAW 264.7 Cell Line is a valuable tool for functional genomics screens, targeted epigenetic studies, and macrophage biology research. Researchers can employ chromatin immunoprecipitation coupled with quantitative PCR (ChIP-qPCR) to map histone modification changes at immunoregulatory loci, RNA sequencing (RNA-seq) for transcriptome-wide dissection of BAHCC1-regulated gene networks, and western blotting to verify candidate protein expression changes. Flow cytometry enables profiling of macrophage surface markers and activation states, while luciferase reporter assays offer quantitative measurement of transcription factor activity downstream of BAHCC1. These applications support investigations into hematological malignancies linked to chromatin dysregulation and inflammatory disorders where macrophage responses are pivotal. For detailed information on validation and availability, please contact Ascent Research.